Similar Papers

Paper Title
Journal
Date
Author
Diabetic macular oedema: evidence-based treatment recommendations for Asian countries.
Gemmy Cm Cheung ... Tara M George
Clinical & experimental ophthalmology | VOL. 46
Gemmy Cm Cheung, et. al.Gemmy Cm Cheung ... Tara M George
21 Jun 2017
Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration
Farshad Abedi ... Paul N Baird
Ophthalmology | VOL. 120
Farshad Abedi, et. al.Farshad Abedi ... Paul N Baird
09 Apr 2013
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA.
Jennifer K Sun ... Sharon D Solomon
Retina | VOL. 43
Jennifer K Sun, et. al.Jennifer K Sun ... Sharon D Solomon
01 Apr 2023
Anti–Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
Jagdeep Singh Gandhi
American Journal of Ophthalmology | VOL. 199
Jagdeep Singh GandhiJagdeep Singh Gandhi
20 Dec 2018
View more papers

More From: Immunity

Paper Title
Journal
Date
Author
A. faecalis induces intestinal T helper 17 cells by promoting E3 ubiquitin ligase Trim21-mediated E3 ubiquitin ligase Fbxw7 degradation.
Yingying Shen ... Zhijian Cai
Immunity | VOL. -
Yingying Shen, et. al.Yingying Shen ... Zhijian Cai
08 Apr 2025
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins.
Jenna J Guthmiller ... Patrick C Wilson
Immunity | VOL. 58
Jenna J Guthmiller, et. al.Jenna J Guthmiller ... Patrick C Wilson
01 Apr 2025
Glia get RIPped in ALS.
Alexis M Johnson ... John R Lukens
Immunity | VOL. 58
Alexis M Johnson, et. al.Alexis M Johnson ... John R Lukens
01 Apr 2025
The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2.
Xiaodan Hu ... Sheng Ding
Immunity | VOL. 58
Xiaodan Hu, et. al.Xiaodan Hu ... Sheng Ding
01 Apr 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.